Announcement.

NESTMEDIC SA (23/2019) Submission of a statement regarding the limitation of the disposal of the Issuer's shares

Legal basis: Article 17 para. 1 MAR - confidential information.
The Management Board of NESTMEDIC S.A. with its registered office in Wrocław ("Company", "Issuer"), hereby informs that on October 11, 2019, the shareholder Patrycja Wizińska-Socha, acting as the President of the Issuer's Management Board ("Shareholder"), made a statement regarding the obligation not to be or not to charge shares of the Issuer ("Statement"). The submission of the Statement by the Shareholder is related to the implementation of the cooperation agreement concluded on July 10, 2019 with the investor Deutsche Balaton Aktiengesellschaft ("Investor"), about which the Issuer informed in ESPI current report no. Aktiengesellschaft), published on July 10, 2019.
By virtue of the submitted Statement, the Shareholder undertook, in relation to 1,359,550 (in words: one million three hundred fifty nine thousand five hundred fifty) shares of the Issuer ("Shares"), with of which:
1) as at the date of submitting the Statement, the Shareholder holds 924.550 shares of the Issuer,
2) the remaining part of the shares, i.e. 435,000 shares, are shares that will be returned to the Shareholder as a result of the return of two share loans, by that the Shareholder notified the Company of (in consequence of which the Issuer published current ESPI reports No. 27/2018 and 38/2018) ,
that without obtaining the prior written consent of the Investor, it will not offer, transfer ownership, establish any encumbrance, grant options, undertake to sell or encumber it, or otherwise dispose of the Shares, directly or indirectly, and will not enter into any contract or transaction that will or could be the basis for the transfer of ownership or other regulation, directly or indirectly, any rights arising from the Shares, or whose economic effect would be equivalent to the regulation rights arising from the ownership of the Shares. The above liability of the Shareholder covered by the Declaration shall apply until July 10, 2022.
In respect of the remaining 65,000 Issuer's Shares, which may be sold without the consent of the Investor, the Shareholder undertook to sell no more than 65,000 owned Shares provided that , that the sale price of one Share will not be lower than PLN 3 (say: threegold).
In the event of disposing of the Shares contrary to the Declaration, i.e. without obtaining the Investor's written consent, the Shareholder undertook to pay the Issuer a guarantee penalty in the amount of PLN 50,000 (in words: fifty thousand zlotys) for each case of unauthorized disposal of the Shares.

Source: company website, investor relations, current and periodic reports.

ALL COMPANY ANNOUNCMENTS
Company information
Company name:Nestmedic SA
ISIN:PLNSTMD00010
NIP:8943054930
Adress: ul. Duńska 9 54-427 Wrocław
Phone:+48 664346559
website:www.nestmedic.com

Copyright © 2017 PolandStockExchange
This website uses cookies (Regulations / Cookie Policy).